Irbesartan And Hydrochlorothiazide Tablet
Product Images NDC 71335-2099

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Irbesartan And Hydrochlorothiazide (NDC 71335-2099). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Irbesartan And Hydrochlorothiazide Figure 1a (22bf08c2 615b 4b48 Af36 1b71a91459dc 01)

A line graph depicting the percentage of subjects with systolic blood pressure (SBP) below 140 mmHg relative to baseline SBP values in mmHg. The graph includes multiple studies labeled as Study V and Study VI, comparing average (Av.) and Irbesartan (Irb.) groups using different line styles and colors.*

FDA Label Image

Irbesartan And Hydrochlorothiazide Figure 1b (22bf08c2 615b 4b48 Af36 1b71a91459dc 02)

A line graph showing the percentage of subjects with systolic blood pressure (SBP) less than 130 mmHg on the Y-axis against baseline SBP (mmHg) on the X-axis. The graph compares five study groups: Av. Study V, Irb. Study V, HCTZ Study V, Av. Study VI, and Irb. Study VI, each represented by distinct colored and styled lines.*

FDA Label Image

Irbesartan And Hydrochlorothiazide Figure 2a (22bf08c2 615b 4b48 Af36 1b71a91459dc 03)

A line graph showing the percentage reduction in diastolic blood pressure (DBP) over a range of baseline DBP values (mmHg), comparing Study V and Study VI data for Irbesartan (Irb) and Hydrochlorothiazide (HCTZ), including average study values. Different line styles represent each dataset.*

FDA Label Image

Irbesartan And Hydrochlorothiazide Figure 2b (22bf08c2 615b 4b48 Af36 1b71a91459dc 04)

A line graph showing the percentage reduction in diastolic blood pressure (DBP) below 80 mmHg plotted against baseline DBP measurements ranging from 90 to 130 mmHg. The graph compares average and individual study data for treatments involving Irbesartan (Irb), Hydrochlorothiazide (HCTZ), and their combination across different studies (V and VI). The legend identifies lines corresponding to these treatments and studies.*

FDA Label Image

Chemical Structure Irbesartan (22bf08c2 615b 4b48 Af36 1b71a91459dc 05)

Chemical structure of Irbesartan, one of the active ingredients in Irbesartan and Hydrochlorothiazide tablets. The diagram depicts the molecular arrangement of the compound used in this prescription medication.*

FDA Label Image

Chemical Structure Hydrochlorothiazide (22bf08c2 615b 4b48 Af36 1b71a91459dc 06)

Chemical structure diagram of the active ingredient Irbesartan, showing its molecular arrangement with labeled atoms and bonds.*

FDA Label Image

Irbesartan And Hydrochlorothiazide Figure 3 (22bf08c2 615b 4b48 Af36 1b71a91459dc 07)

A scatter plot with a curve showing the placebo-subtracted reduction in trough SeSBP as a function of Irbesartan dose (mg/day). The y-axis represents blood pressure in mmHg, and the x-axis represents Irbesartan dose, ranging from 0 to 900 mg/day. Data points are scattered, with a curve indicating the trend.*

FDA Label Image

Irbesartan And Hydrochlorothiazide Figure 4 (22bf08c2 615b 4b48 Af36 1b71a91459dc 08)

A scatter plot with a fitted curve showing the relationship between Irbesartan dose (mg/day) on the x-axis and placebo-subtracted reduction in trough SeDBP (mmHg) on the y-axis. The graph illustrates dose-dependent blood pressure reduction data from an integrated analysis.*

FDA Label Image

Label (Lbl713352099)

Label for Irbesartan and Hydrochlorothiazide 150 mg/12.5 mg tablet by Bryant Ranch Prepack. The label references comparison to Avalide 150/12.5 mg tablet and shows storage instructions to keep at 20°-25°C (68°-77°F). The package contains 30 tablets and includes a barcode and NDC 71335-2099-91.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.